CD38线CD8+T,

Lei-Lei Lv1, Jia-Wei Zhai1,2, Jia-Juan Wu3

  • 1Department of Respiratory and Critical Medicine, the First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, 215006, China.

概括

CD38hiCD8+ 肺癌中的T细胞通过线粒体功能障碍与免疫疗法抵抗有关. 通过EGCG和PD-1阻断向CD38,可以恢复T细胞功能并改善治疗反应.